Tenax Therapeutics Inc

The current institutional shareholding score of Tenax Therapeutics Inc is 5.00, ranking 133 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 51.15%, representing a quarter-over-quarter decrease of 51.74%. The largest institutional shareholder is Steven Cohen, holding a total of 718.86K shares, representing 1.06% of shares outstanding, with 47.34% decrease in holdings.